$60.5 Million is the total value of Healthcare Value Capital, LLC's 22 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 35.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANIP | Buy | ANI PHARMACEUTICALS INC | $14,440,000 | +16.0% | 320,000 | +1.6% | 23.89% | +34.6% |
| AMRI | ALBANY MOLECULAR RESH INC | $7,988,000 | +14.0% | 402,400 | 0.0% | 13.21% | +32.2% | |
| QLTI | QLT INC | $5,738,000 | 0.0% | 2,157,200 | 0.0% | 9.49% | +16.0% | |
| PFE | PFIZER INC | $4,842,000 | +2.8% | 150,000 | 0.0% | 8.01% | +19.2% | |
| DGX | QUEST DIAGNOSTICS INC | $4,710,000 | +15.7% | 66,208 | 0.0% | 7.79% | +34.2% | |
| CRY | CRYOLIFE INC | $3,989,000 | +10.8% | 370,000 | 0.0% | 6.60% | +28.5% | |
| DEPO | New | DEPOMED INC | $3,626,000 | – | 200,000 | +100.0% | 6.00% | – |
| AGN | ALLERGAN PLC | $3,125,000 | +15.0% | 10,000 | 0.0% | 5.17% | +33.4% | |
| GSK | Sell | GLAXOSMITHKLINE PLCcall | $2,018,000 | -47.5% | 50,000 | -50.0% | 3.34% | -39.1% |
| TWM | PROSHARES TRcall | $1,965,000 | -9.4% | 50,000 | 0.0% | 3.25% | +5.1% | |
| TWM | PROSHARES TRultsht russ2000 | $1,965,000 | -9.4% | 50,000 | 0.0% | 3.25% | +5.1% | |
| ANIP | ANI PHARMACEUTICALS INCcall | $1,128,000 | +14.2% | 25,000 | 0.0% | 1.87% | +32.4% | |
| CYTK | CYTOKINETICS INC | $1,046,000 | +56.4% | 100,000 | 0.0% | 1.73% | +81.3% | |
| AMRN | AMARIN CORP PLCcall | $756,000 | -2.1% | 400,000 | 0.0% | 1.25% | +13.6% | |
| MNKD | Sell | MANNKIND CORPput | $725,000 | -81.2% | 500,000 | -58.3% | 1.20% | -78.2% |
| FCSC | FIBROCELL SCIENCE INC | $672,000 | +18.1% | 147,769 | 0.0% | 1.11% | +37.1% | |
| ZGNX | ZOGENIX INC | $469,000 | +9.1% | 31,850 | 0.0% | 0.78% | +26.6% | |
| PTX | New | PERNIX THERAPEUTICS HLDGS IN | $443,000 | – | 150,000 | +100.0% | 0.73% | – |
| SRNE | SORRENTO THERAPEUTICS INC | $436,000 | +3.8% | 50,000 | 0.0% | 0.72% | +20.4% | |
| APRI | Sell | APRICUS BIOSCIENCES INC | $139,000 | -85.4% | 140,000 | -78.5% | 0.23% | -83.0% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INCcall | $135,000 | -63.0% | 150,000 | -66.7% | 0.22% | -57.2% |
| APRI | APRICUS BIOSCIENCES INCcall | $99,000 | -32.2% | 100,000 | 0.0% | 0.16% | -21.2% | |
| ALIM | Exit | ALIMERA SCIENCES INC | $0 | – | -100,000 | -100.0% | -0.32% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.32% | – |
| ARIA | Exit | ARIAD PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.42% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.97% | – |
| ALQA | Exit | ALLIQUA BIOMEDICAL INC | $0 | – | -421,000 | -100.0% | -1.90% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -25,000 | -100.0% | -1.94% | – |
| MYL | Exit | MYLAN N Vcall | $0 | – | -50,000 | -100.0% | -2.87% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -200,000 | -100.0% | -9.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.